Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAMYT.L Share News (AMYT)

  • There is currently no data for AMYT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK Stocks-Factors to watch on March 15

Thu, 15th Mar 2018 05:25

March 15 (Reuters) - Britain's FTSE 100 index is seen opening 2points higher at 7,135 on Thursday, according to financial bookmakers. * SHELL: Royal Dutch Shell is close to bagging a deal to supplyHong Kong with liquefied natural gas (LNG), beating out major competitors forthe right to be the first company to supply LNG to the area. * GLENCORE: Glencore Plc, the world's biggest producer of cobalt,has agreed to sell around a third of its cobalt production over the next threeyears to Chinese battery recycler GEM Co Ltd, according to a filingby GEM on Wednesday. * BHP: BHP's Escondida copper mine in Chile, the world's largest,said on Wednesday that it has invited its powerful workers' union to start earlytalks on a new collective labor contract. * GOLD: Gold prices edged higher early Thursday and hovered near one-weekhighs hit in the previous session, as concerns over trade tensions weighed onshare markets. * OIL: Oil prices held steady on Thursday, supported by healthy globaldemand but capped by the relentless rise in U.S. production that is underminingefforts led by producer cartel OPEC to cut supplies and prop upmarkets. * EX-DIVS: Anglo American and Hammerson will trade withoutentitlement to their latest dividend pay-out on Thursday, trimming 1.37 pointsoff the FTSE 100 according to Reuters calculations. * The UK blue chip FTSE 100 index closed down 0.09 percent at7,132.69 points on Wednesday, as shares gave up early gains and finished innegative territory as points gained by Prudential and mining stocks wereoverturned by simmering fears of a global trade war that pushed Wall Street intothe red. * For more on the factors affecting European stocks, please click on: cpurl://apps.cp./cms/?pageId=livemarkets * UK CORPORATE DIARY: Phoenix Group Full Year 2017 Earnings Release OneSavings Bank Full Year 2017 Earnings Release Amryt Pharma PLC Q4 2017 Trading Statement Release Spirax-Sarco Engineering Full Year 2017 Earnings Release PV Crystalox Solar Full Year 2017 Earnings Release Old Mutual PLC Full Year 2017 Earnings Release Kier Group PLC Half Year 2018 Earnings Release Just Group PLC Full Year 2017 Earnings Release Savills Plc Full Year 2017 Earnings Release Cineworld Group plc Full Year 2017 Earnings Release TODAY'S UK PAPERS > Financial Times > Other business headlines Multimedia versions of Reuters Top News are now available for: * 3000 Xtra : visit http://topnews.session.rservices.com * For Top News : http://topnews.reuters.com (Reporting by Siju Varghese)
More News
28 Feb 2019 14:06

Redx Pharma Issues 750,000 Shares In Order To Reduce Headquarter Lease (ALLISS)

LONDON (Alliance News) - Biotechnology firm Redx Pharma PLC on Thursday said it has changed the lease agreement at its Alderley Park headquarters in Cheshire, England, reducing the amount of will

Read more
28 Feb 2019 12:12

Amryt Pharma Now Permitted To Enrol Children Under Four In Ease Trial

LONDON (Alliance News) - Amryt Pharma PLC on Thursday said it now has permission to enrol infants and children under four years old in its ongoing phase three Ease trial of AP101 in the Ease will

Read more
7 Jan 2019 09:41

Amryt Pharma Reports Positive Results For Gene Therapy In Skin Disease

LONDON (Alliance News) - Amryt Pharma PLC on Monday reported positive results from two pre-clinical studies of its novel non-viral gene therapy for recessive dystrophic epidermolysis company said

Read more
4 Jan 2019 14:41

Amryt Pharma given go-ahead to continue Phase III EASE trial

(Sharecast News) - Revenue-generating orphan drug company Amryt Pharma announced the results of an unblinded interim efficacy analysis on its pivotal Phase III EASE trial for AP101 as a potential treatment for Epidermolysis Bullosa (EB) on Friday.

Read more
4 Jan 2019 13:32

Committee Recommends Adding More Patients To Amryt Pharma's Ease Trial

LONDON (Alliance News) - Amryt Pharma PLC on Friday said an independent data monitoring committee has recommended adding more patients to its phase three Ease trial of epidermolysis bullosa drug a

Read more
19 Dec 2018 11:22

Amryt Pharma flags slight delay to EASE trial data

(Sharecast News) - Orphan drug company Amryt Pharma updated the market on the global AP101 EASE Phase III clinical trial being conducted in patients with Epidermolysis Bullosa (EB) on Wednesday, reporting that the independent data monitoring committee was scheduled to meet on 21 December to review the EASE unblinded interim efficacy analysis results.

Read more
10 Dec 2018 16:39

Amryt Pharma scores €8.4m grant from Irish government

(Sharecast News) - Amryt Pharma announced on Monday that it has secured am €8.4m grant from the Irish Government for three years of development of its AP103 gene therapy platform.

Read more
10 Dec 2018 12:12

Amryt Pharma Secures Irish Government Grant To Develop AP103 Platform

LONDON (Alliance News) - Amryt Pharma PLC on Monday said it has secured grant funding of EUR8.4 million over three years to develop its AP103 gene therapy platform.Amryt shares were trading

Read more
17 Oct 2018 11:31

Amryt Pharma reaches agreement with French authorities over Lojuxta

(Sharecast News) - Orphan drug company Amryt Pharma has reached agreement with France's Comité économique des produits de santé (CEPS) to reimburse 'Lojuxta' (lomitapide) for the treatment of adult patients with homozygous familial hypercholesterolaemia (HoFH) in France.

Read more
26 Sep 2018 12:47

Amryt Narrows Half Year Loss On Lojuxta Sales And Lower Expenses

LONDON (Alliance News) - Oprhan drug company Amryt Pharma PLC said Wednesday its loss narrowed in the first half of 2018 due to increased sales of its rare disease drug Lojuxta and reduced the six

Read more
2 Aug 2018 12:15

Amryt Pharma Gets Rare Pediatric Disease Designation For AP101

LONDON (Alliance News) - Amryt Pharma PLC said Thursday that the US Food & Drug Administration has granted a rare pediatric disease designation for AP101, used for the treatment of Bullosa is

Read more
19 Jul 2018 12:47

Amryt Pharma Confident In 2018 With Strong First-Half Revenue Growth

LONDON (Alliance News) - Amryt Pharma PLC said on Thursday it expects its performance for 2018 to be in line with current market expectations, following strong trading in the first half.The

Read more
9 Jul 2018 10:46

Amryt Pharma Gets NHS Approval For Cholesterol Drug Lojuxta

LONDON (Alliance News) - Amryt Pharma PLC on Monday said its cholesterol reducing drug, Lojuxta, has been approved by the NHS in England.The pharmaceutical company, which focuses on rare in

Read more
29 May 2018 10:54

Amryt Pharma Gets Four Distribution Deals For Lojuxta In Middle East

LONDON (Alliance News) - Amryt Pharma PLC on Tuesday said it signed four distribution deals for its cholesterol disorder drug Lojuxta across the Middle East.The biopharmaceutical company it

Read more
10 May 2018 13:25

Amryt Pharma Extends Lojuxta Licence Deal Into New Territories

LONDON (Alliance News) - Amryt Pharma PLC on Thursday said it has expanded its Lojuxta licence agreement with Aegerion Pharmaceuticals Inc into Russia, the Commonwealth of Independent States, and

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.